17-hydroxyjolkinolide b has been researched along with ag-490 in 1 studies
| Studies (17-hydroxyjolkinolide b) | Trials (17-hydroxyjolkinolide b) | Recent Studies (post-2010) (17-hydroxyjolkinolide b) | Studies (ag-490) | Trials (ag-490) | Recent Studies (post-2010) (ag-490) |
|---|---|---|---|---|---|
| 6 | 0 | 4 | 732 | 2 | 322 |
| Protein | Taxonomy | 17-hydroxyjolkinolide b (IC50) | ag-490 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.9224 | |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 3.38 | |
| large T antigen | Betapolyomavirus macacae | 14.61 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Ma, X; Qin, G; Shen, S; Wang, H; Wang, Y; Yan, S; Yu, Q; Zhu, H | 1 |
1 other study(ies) available for 17-hydroxyjolkinolide b and ag-490
| Article | Year |
|---|---|
17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Diterpenes; Drugs, Chinese Herbal; Euphorbia; Humans; Interleukin-6; Janus Kinase 2; Janus Kinases; Neoplasms; Signal Transduction; STAT3 Transcription Factor; Tyrphostins | 2009 |